Luye Pharma Group Ltd (LUP) — Net Asset Quality Index
Luye Pharma Group Ltd (LUP) has a Net Asset Quality Index of 55.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €32.83 Billion minus total liabilities of €14.47 Billion yields net assets of €18.36 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Luye Pharma Group Ltd (LUP) liquidity interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Luye Pharma Group Ltd Net Asset Quality Index Over Time (2016–2025)
This chart shows how Luye Pharma Group Ltd's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 55.9%, representing net assets of €18.36 Billion against total assets of €32.83 Billion EUR. Explore Luye Pharma Group Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Luye Pharma Group Ltd (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Luye Pharma Group Ltd from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Luye Pharma Group Ltd stock valuation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 55.9% | €18.36 Billion | €32.83 Billion | €14.47 Billion | ▲ +2.7 pp |
| 2024 | 53.2% | €15.75 Billion | €29.61 Billion | €13.86 Billion | ▲ +0.1 pp |
| 2023 | 53.1% | €13.53 Billion | €25.49 Billion | €11.96 Billion | ▲ +7.5 pp |
| 2022 | 45.5% | €11.04 Billion | €24.25 Billion | €13.21 Billion | ▲ +5.2 pp |
| 2021 | 40.4% | €9.11 Billion | €22.58 Billion | €13.47 Billion | ▲ +1.1 pp |
| 2020 | 39.3% | €8.10 Billion | €20.63 Billion | €12.53 Billion | ▼ -9.3 pp |
| 2019 | 48.5% | €9.37 Billion | €19.31 Billion | €9.94 Billion | ▲ +3.3 pp |
| 2018 | 45.2% | €7.93 Billion | €17.54 Billion | €9.60 Billion | ▼ -18.8 pp |
| 2017 | 64.1% | €6.90 Billion | €10.76 Billion | €3.86 Billion | ▼ -7.2 pp |
| 2016 | 71.3% | €6.56 Billion | €9.21 Billion | €2.64 Billion | — |